pharmaceutical industry

See the following -

Chaotic Drug Distribution Threatens Nigeria’s Health Sector

Staff Writer | BusinessDay | August 23, 2013

As counterfeit medicines continue to impact negatively on consumers, exposing them to dangerous and ineffective medical products, industry experts have expressed concern over the chaotic drug distribution system and sale of drugs in the open market, which is eroding the confidence of Nigeria’s pharmaceutical sector and threatening the health sector. Read More »

ClinGenuity Uses Artificial Intelligence Redaction Tool To Keep Big Pharma Compliant

Press Release | ClinGenuity | July 31, 2014

ClinGenuity, the Cincinnati medical writing company with the pharmaceutical industry's first and only artificially-intelligent automated redaction management tool, has processed more than a half billion redactions for big pharma companies to help them meet the growing industry demand for pharmaceutical clinical trial disclosure and transparency initiatives...

Read More »

Clinovo Announces New Customer Win For Its ClinCapture Open-Source Electronic Data Capture System

Press Release | Clinovo | June 28, 2013

Leading Pharmaceutical Company Starts Phase II Ophthalmology Clinical Trial With Silicon Valley based CRO Clinovo for Electronic Data Capture (EDC), Clinical Data Management (CDM), Biostatistics, and Medical Writing Services Read More »

Doctors Denounce Cancer Drug Prices Of $100,000 A Year

Andrew Pollack | New York Times | April 25, 2013

With the cost of some lifesaving cancer drugs exceeding $100,000 a year, more than 100 influential cancer specialists from around the world have taken the unusual step of banding together in hopes of persuading some leading pharmaceutical companies to bring prices down. Read More »

Doctors Promoting Treatments on Social Media Routinely Fail to Disclose Ties to Drug Makers

Sheila Kaplan | STAT | February 29, 2016

Physicians across the United States routinely offer medical advice on social media — but often fail to mention that they have accepted tens and sometimes hundreds of thousands of dollars from the companies that make the prescription drugs they tout. A STAT examination of hundreds of social media accounts shows that health care professionals virtually never note their conflicts of interest, some of them significant, when promoting drugs or medical devices on sites such as Facebook, Instagram, and Twitter. The practice cuts across all specialties...

Read More »

Doctors' Dubious Excuses For Taking Pharmaceutical Companies' Money

Roy M. Poses | Health Care Renewal | March 19, 2013

Pro Publica has updated their database of payments by pharmaceutical payments to physicians and organizations.  It now has data from 15 companies totaling more than $2 billion from 2009 to 2012. To accompany Pro Publica's report, a number of news outlets wrote about payments given to local or regional doctors... Read More »

Dollars For Docs Mints A Millionaire

Tracy Weber and Charles Ornstein | ProPublica | March 11, 2013

Dr. Jon W. Draud, the medical director of psychiatric and addiction medicine at two Tennessee hospitals, pursues some eclectic passions. He’s bred sleek Basenji hunting dogs for show. And last summer, the Tennessee State Museum featured “African Art: The Collection of Jon Draud.” Read More »

Don’t Give More Patients Statins

John D. Abramson and Rita F. Redberg | New York Times | November 13, 2013

ON Tuesday, the American Heart Association and the American College of Cardiology issued new cholesterol guidelines that essentially declared, in one fell swoop, that millions of healthy Americans should immediately start taking pills — namely statins — for undefined health “benefits.” Read More »

Drop The Antibiotics, We Need A New Battle Plan Against Bacteria

Alice Roberts | The Guardian | January 19, 2013

For 80 years antibiotics have helped us to fight disease. But bacteria are growing resistant – so it's time we stopped treating winter colds with such a powerful weapon Read More »

Drugs You Don't Need For Disorders You Don't Have

Jonathon Cohn | The Huffington Post | March 31, 2016

One evening in the late summer of 2015, Lisa Schwartz was watching television at her Vermont home when an ad for a sleeping pill called Belsomra appeared on the screen. Schwartz, a longtime professor at Dartmouth Medical College, usually muted commercials, but she watched this one closely: a 90-second spot featuring a young woman and two slightly cute, slightly creepy fuzzy animals in the shape of the words “sleep” and “wake”...

Read More »

Eli Lilly Officially Sues Canada For 'Lost Profits' Because Canada Rejected Eli Lilly's Patents

Mike Masnick | Techdirt | September 13, 2013

A few years ago, we noted that Eli Lilly was facing some hard times, in large part because it had focused its entire business model around getting patents, and many of those patents were expiring, and very few new ones were in the pipeline. Even so, it was still rather surprising earlier this year to see Eli Lilly claim that Canada owed it $100 million for undermining the company's "expected future profits" by rejecting an Eli Lilly patent. Read More »

Elizabeth Warren Questions FDA Rules for Limiting Antibiotics on Farms

Venessa Wong | Bloomberg Businessweek | March 14, 2014

New voluntary rules to limit the use of antibiotics in agriculture aren’t enough to satisfy Senator Elizabeth Warren (D-Mass.). [...] Read More »

EU Agency Lifts Lid on Drug Data Secrets

Ben Hirschler | Reuters | July 15, 2012

Europe's medicines regulator, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny in a move that will let independent researchers trawl through millions of pages of clinical trial information. Read More »

Expensive Prescription Drugs: A Few Resources For Those In Need

Jeanne Pinder | Clear Health Costs | June 3, 2013

We’ve all heard about astonishingly expensive  drugs, and about drug company resources for helping people afford them. Read More »

Farm-Drug Companies Agree To Antibiotics Ban. More Of The Same, Or Fresh Start?

Maryn McKenna | Wired | March 28, 2014

Big news in the realm of agricultural antibiotics: For the first time in almost 37 years of trying, the US Food and Drug Administration has achieved some control over the meat-industry practice of routinely giving antibiotics to livestock. The drawback: The control comes in the form of a voluntary commitment by veterinary drug manufacturers [...]. Read More »